These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 1723797
1. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Gough B, Ali SF, Slikker W, Holson RR. Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797 [Abstract] [Full Text] [Related]
2. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study. Gough B, Imam SZ, Blough B, Slikker W, Ali SF. Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116 [Abstract] [Full Text] [Related]
3. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Hiramatsu M, Cho AK. Neuropharmacology; 1990 Mar; 29(3):269-75. PubMed ID: 1691459 [Abstract] [Full Text] [Related]
4. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates. Hiramatsu M, DiStefano E, Chang AS, Cho AK. Eur J Pharmacol; 1991 Nov 05; 204(2):135-40. PubMed ID: 1725282 [Abstract] [Full Text] [Related]
5. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR. Toxicol Appl Pharmacol; 1988 Jul 05; 94(3):448-57. PubMed ID: 2456631 [Abstract] [Full Text] [Related]
6. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Frederick DL, Ali SF, Slikker W, Gillam MP, Allen RR, Paule MG. Neurotoxicol Teratol; 1995 Jul 05; 17(5):531-43. PubMed ID: 8551999 [Abstract] [Full Text] [Related]
7. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Nash JF, Nichols DE. Eur J Pharmacol; 1991 Jul 23; 200(1):53-8. PubMed ID: 1722755 [Abstract] [Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI. Psychopharmacology (Berl); 2001 Mar 23; 154(3):251-60. PubMed ID: 11351932 [Abstract] [Full Text] [Related]
9. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment. Heidbreder C, Gewiss M, De Potter W, De Witte P. Arch Int Physiol Biochim Biophys; 1992 Mar 23; 100(3):267-73. PubMed ID: 1382678 [Abstract] [Full Text] [Related]
10. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Yamamoto BK, Spanos LJ. Eur J Pharmacol; 1988 Mar 29; 148(2):195-203. PubMed ID: 2897922 [Abstract] [Full Text] [Related]
12. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ, Whittington PE, Audsley AR. Brain Res; 1986 Dec 10; 399(2):339-45. PubMed ID: 2435361 [Abstract] [Full Text] [Related]
13. In vivo output of dopamine and metabolites from the rat caudate nucleus as estimated with push-pull perfusion on-line with HPLC-EC in unrestrained, conscious rats. I. Chromatographic and biological validation. Chen JC, Rhee KK, Beaudry DM, Ramirez VD. Neuroendocrinology; 1984 May 10; 38(5):362-70. PubMed ID: 6203048 [Abstract] [Full Text] [Related]
14. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Nash JF. Life Sci; 1990 May 10; 47(26):2401-8. PubMed ID: 1979830 [Abstract] [Full Text] [Related]
15. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR, Paule MG, Slikker W. Neurotoxicol Teratol; 1993 May 10; 15(2):91-6. PubMed ID: 7685472 [Abstract] [Full Text] [Related]
16. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo. Miyake H, Chiueh CC. Eur J Pharmacol; 1989 Jul 04; 166(1):49-55. PubMed ID: 2478372 [Abstract] [Full Text] [Related]
17. In vivo on-line HPLC-microdialysis: simultaneous detection of monoamines and their metabolites in awake freely-moving rats. Chaurasia CS, Chen CE, Ashby CR. J Pharm Biomed Anal; 1999 Mar 04; 19(3-4):413-22. PubMed ID: 10704106 [Abstract] [Full Text] [Related]
18. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. Johnson MP, Huang XM, Nichols DE. Pharmacol Biochem Behav; 1991 Dec 04; 40(4):915-22. PubMed ID: 1726189 [Abstract] [Full Text] [Related]
19. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Schmidt CJ, Wu L, Lovenberg W. Eur J Pharmacol; 1986 May 13; 124(1-2):175-8. PubMed ID: 2424776 [Abstract] [Full Text] [Related]
20. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine. Bailey BA, Philips SR, Boulton AA. Neurochem Res; 1987 Feb 13; 12(2):173-8. PubMed ID: 2437473 [Abstract] [Full Text] [Related] Page: [Next] [New Search]